December 19, 2025

Semler Scientific, Inc. (SMLR) Investor Outlook: Unlocking a 283.79% Potential Upside in the Medical Devices Sector

Semler Scientific, Inc. (NASDAQ: SMLR), a key player in the healthcare sector, specifically within the medical devices industry, is garnering attention for its innovative technology solutions that enhance the clinical..

InMode Ltd. (INMD) Stock Analysis: Navigating the Healthcare Sector with a 14% Potential Upside

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector specializing in medical devices, commands attention with its innovative minimally invasive aesthetic solutions. Headquartered in Yokne’am, Israel, InMode has..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a Near 95% Upside Potential in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a company at the forefront of medical innovations in the healthcare sector, presents a compelling investment case for those looking to capitalize on growth within the..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 72% Potential Upside with Strong Buy Ratings

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has drawn considerable attention from investors, bolstered by an impressive 72.27% potential upside and unanimous buy ratings from analysts. As..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unpacking the 214.67% Potential Upside in Biotech Vision Solutions

LENZ Therapeutics, Inc. (LENZ), a promising player in the biotechnology industry, has captured investor attention with its significant potential upside of 214.67%. Focused on developing therapies to improve vision, particularly..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising Biotech with 117% Revenue Growth and Strong Buy Ratings

Stoke Therapeutics, Inc. (NASDAQ: STOK) has captured the attention of investors with its innovative approach to treating genetic diseases and recent financial performance. As a biotechnology company focused on upregulating..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 25.5% Potential Upside in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out in the biotechnology sector, a field known for its dynamic and high-risk, high-reward nature. With a market capitalization of $873.15 million, Arbutus is..

AxoGen, Inc. (AXGN) Stock Analysis: Analysts See 11.81% Upside in Innovative Nerve Repair Solutions

AxoGen, Inc. (NASDAQ: AXGN), a pioneering force in the medical devices sector, particularly in the niche of peripheral nerve regeneration and repair, has been capturing the attention of investors and..

EyePoint Pharmaceuticals (EYPT): Analyst Ratings Signal a Promising 108% Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a key player in the biotechnology sector, is capturing investor attention with its groundbreaking approach to tackling severe retinal diseases. With a market capitalization of..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 465% Potential Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL), a prominent player in the biotechnology sector, is grabbing investor attention with its staggering potential upside of 465.55%. Specializing in the development of innovative..

PureTech Health plc (PRTC): A Biotech Contender with Explosive Revenue Growth and Strategic Innovations

In the dynamic world of biotechnology, PureTech Health plc (NASDAQ: PRTC) distinguishes itself not only with its innovative pipeline but also with an astounding revenue growth of 542.70%. This remarkable..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 20.33% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a key player in the healthcare staffing industry, presents an interesting proposition for investors looking to navigate the complexities of the current healthcare market...

Oculis Holding AG (OCS) Stock Report: Exploring a Potential 130.80% Upside in Ophthalmic Innovation

Oculis Holding AG (NASDAQ: OCS), a Swiss-based biotechnology company at the forefront of ophthalmic innovation, has been capturing the attention of investors due to its promising clinical-stage drug candidates and..

COMPASS Pathways Plc (CMPS): Investor Outlook with a 170% Upside Potential in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing opportunity for investors seeking exposure to the burgeoning mental health treatment sector. With its focus on innovative psilocybin therapy, COMPASS is pioneering..

Auna SA (AUNA) Stock Analysis: Exploring a 126% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a prominent player in the healthcare sector, has captured investor attention with its significant potential upside. Headquartered in Luxembourg, this medical care facilities provider operates hospitals and..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a 123% Potential Upside for Investors

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN), a pioneering entity in the biotechnology sector, is capturing investor interest with its promising pipeline of treatments for pediatric and adult diseases. With a..

MeiraGTx Holdings (MGTX) Stock Analysis: Unveiling a 237% Potential Upside Opportunity

MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage genetic medicines company, is drawing significant attention from investors with an eye for high-growth opportunities in the healthcare sector. Based in New York,..

Tectonic Therapeutic, Inc. (TECX) Stock Report: Analyst Consensus Points to a Potential 328% Upside

For investors with an eye on revolutionary biotechnology companies, Tectonic Therapeutic, Inc. (NASDAQ: TECX) is a promising player with significant upside potential. The company’s innovative approach to targeting G protein-coupled..

SIGA Technologies Inc. (SIGA) Stock Report: A Closer Look at Its Strong Return on Equity Amidst Revenue Decline

For individual investors keen on the healthcare sector, SIGA Technologies Inc. (SIGA) presents a unique case study. Operating in the niche market of pharmaceutical products focused on health security, SIGA..

Claritev Corporation (CTEV) Stock Analysis: Unpacking a 106.76% Potential Upside in the Healthcare Sector

Claritev Corporation (CTEV), a key player in the healthcare industry, is making waves with a staggering potential upside of 106.76% based on analyst target prices. Specializing in data analytics and..

Search

Funds

December 19, 2025

Search

Funds

December 19, 2025

FTSE 100

Funds